Slingshot members are tracking this event:

Sunovion Announces Publication of Data Evaluating Dose Escalation of Latuda (lurasidone HCl) in the Treatment of Schizophrenia

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
Sunovion Pharmaceuticals

Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 08, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Lurasidone Hci, Latuda, Schizophrenia